4.7 Article

Evaluating Ocular Symptoms and Tear Film Cytokine Profiles in Symptomatic COVID-19 Patients

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Ocular manifestations of COVID-19: facts and figures from a tertiary care center

Nissar Shaikh et al.

Summary: This study aims to report the incidence of ocular signs and symptoms in COVID-19 patients and find any correlation between the occurrence of ocular manifestations and patients' comorbidities. The study found a lower occurrence of ocular manifestations compared to existing literature, and no significant association between the occurrence of ocular manifestations and the patient's gender or comorbidities.

ANNALS OF MEDICINE (2022)

Article Microbiology

Ocular Surface Infection by SARS-CoV-2 in COVID-19 Pneumonia Patients Admitted to Sub-Intensive Unit: Preliminary Results

Mario Troisi et al.

Summary: The aim of this study was to investigate the relationship between virus detection on conjunctival swabs and systemic and ocular clinical data, treatments, and the administration of supplemental oxygen. The results suggest that exposure of unprotected eyes to aerosols containing high concentrations of SARS-CoV-2 may cause a keratoconjunctival viral infection.

MICROORGANISMS (2022)

Review Public, Environmental & Occupational Health

Ocular transmission and manifestation for coronavirus disease: a systematic review

Ahmed Almazroa et al.

Summary: This study investigated the ocular transmission and manifestations of SARS-CoV-2. The findings suggest that the eye can be infected by SARS-CoV-2, and conjunctivitis is an indicative symptom. However, there is currently no evidence that the eye can serve as an additional path of transmission for SARS-CoV-2.

INTERNATIONAL HEALTH (2022)

Article Ophthalmology

Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19

Ritu Arora et al.

Summary: The study found that 24% of patients with laboratory-proven moderate to severe COVID-19 had detectable SARS-CoV-2 RNA in tears, suggesting tears could be a potential route for viral transmission.

OPHTHALMOLOGY (2021)

Article Microbiology

Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?

Francesco Petrillo et al.

Summary: The global COVID-19 pandemic has highlighted the potential role of the ocular surface in virus transmission. Research has shown that certain commercially available eye drops demonstrate dose-dependent inhibition of viral replication against SARS-CoV-2, suggesting their use as potential antiviral drugs.

MICROORGANISMS (2021)

Letter Medicine, General & Internal

2019-nCoV transmission through the ocular surface must not be ignored

Cheng-wei Lu et al.

LANCET (2020)

Letter Ophthalmology

Ocular manifestation, eye protection, and COVID-19

Rujittika Mungmungpuntipantip et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)

Article Multidisciplinary Sciences

Ocular surface manifestation of COVID-19 and tear film analysis

Alessandro Meduri et al.

SCIENTIFIC REPORTS (2020)

Article Ophthalmology

Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients

Barbara Burgos-Blasco et al.

EXPERIMENTAL EYE RESEARCH (2020)

Review Ophthalmology

Are eyes the windows to COVID-19? Systematic review and meta-analysis

Rina La Distia Nora et al.

BMJ OPEN OPHTHALMOLOGY (2020)

Article Virology

Infection and Replication of Influenza Virus at the Ocular Surface

Hannah M. Creager et al.

JOURNAL OF VIROLOGY (2018)

Review Microbiology

Ocular Tropism of Respiratory Viruses

Jessica A. Belser et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2013)